<DOC>
	<DOCNO>NCT01270256</DOCNO>
	<brief_summary>The purpose study see nasal steroid drug deliver nose NasoNeb™ inhaler improve symptoms people perennial allergic rhinitis ( year round allergy symptom ) .</brief_summary>
	<brief_title>NasoNeb Delivery Intranasal Steroid</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Inclusion Criteria 1 . Males females 18 55 year age . 2 . History perennial allergic rhinitis . 3 . Positive skin test dust mite , dog , cat indoor mold antigen . 4 . And combine nasal AM PM score ≥4 nasal congestion day precede entry total nasal symptom score great 8 . Exclusion Criteria 1 . Physical sign symptom suggestive renal , hepatic cardiovascular disease . 2 . Pregnant lactating woman . 3 . Subjects treat systemic steroid previous 30 day . 4 . Subjects treat topical ( inhaled , intranasal intraocular ) steroid , Nasalcrom Opticrom previous 30 day . 5 . Subjects treat oral antihistamine/decongestants previous seven day . 6 . Subjects treat topical ( intranasal intraocular ) antihistamine/decongestants previous 3 day . 7 . Subjects treat immunotherapy escalate dose . 8 . Subjects chronic antiasthma medication . 9 . Subjects polyps nose significantly displace septum . 10 . Upper respiratory infection within 14 day prior study start .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>allergy</keyword>
</DOC>